Pfizer Inc (PFE): who owns it and who trades it
As of Nov 16, 2026, PFE insiders reported 2 open-market sales worth $135K and 3 purchases worth $3M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jennifer B. Damico (Vice president), with $135K. 10 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Pfizer
From the latest filingsOverall: about as much buying as selling. Congress mostly sold. Insiders and famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PFE
2,814 funds and institutions reported PFE shares worth $101B at the end of Q2 2026, about 71% of the company. The largest holder is BlackRock, Inc. with 9.3%.
Funds and institutions (13F) 71%Everyone else 29%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 529.67M | 9.29% | $12.8B | +6% |
| Vanguard Capital Management LLC | 372.15M | 6.53% | $9B | +1% |
| State Street Corp | 307.09M | 5.39% | $7.4B | +2% |
| California State Teachers Retirement System | 217.98M | 3.82% | $9.1B | +2321% |
| Geode Capital Management, LLC | 135.28M | 2.37% | $3.2B | +1% |
| Vanguard Portfolio Management LLC | 119.24M | 2.09% | $2.9B | +2% |
| Fisher Asset Management, LLC | 109.07M | 1.91% | $2.6B | +4% |
| Morgan Stanley | 96.35M | 1.69% | $2.3B | +4% |
| Norges Bank | 61.51M | 1.08% | $1.5B | – |
| Northern Trust Corp | 59.08M | 1.04% | $1.4B | -5% |
| Bank of New York Mellon Corp | 57.88M | 1.02% | $1.4B | +7% |
| Massachusetts Financial Services Co | 56.55M | 0.99% | $1.4B | -1% |
| State Farm Mutual Automobile Insurance Co | 54.51M | 0.96% | $1.3B | No change |
| Goldman Sachs Group Inc | 52.99M | 0.93% | $1.3B | +12% |
| Charles Schwab Investment Management Inc | 52.55M | 0.92% | $1.3B | +1% |
| Bank of America Corp | 43.59M | 0.76% | $1B | -6% |
| Legal & General Group Plc | 43.23M | 0.76% | $1B | -1% |
| Dimensional Fund Advisors LP | 38.06M | 0.67% | $917M | +4% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 36.16M | 0.63% | $871M | +5% |
| Amundi | 33.53M | 0.59% | $807M | -18% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PFE insiders reported $3M of open-market purchases and $135K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Albert Bourla | CEO | Purchase | 38,000 | $26.34 | $1M | Form 4 |
| Aug 5, 2026 | Jennifer B. Damico | Vice president | Sale | 3,278 | $25.40 | $83.3K | Form 4 |
| Aug 5, 2026 | Ronald E Blaylock | Director | Purchase | 39,231 | $25.46 | $999K | Form 4 |
| Aug 5, 2026 | Mortimer J Buckley | Director | Purchase | 37,632 | $25.52 | $960K | Form 4 |
| Jun 9, 2026 | Jennifer B. Damico | Vice president | Sale | 2,000 | $25.70 | $51.4K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Albert Bourla | Chairman & CEO, Director | $1M | – | Aug 12, 2026 |
| Ronald E Blaylock | Director | $999K | – | Aug 5, 2026 |
| Mortimer J Buckley | Director | $960K | – | Aug 5, 2026 |
| Jennifer B. Damico | SVP & Controller | – | $135K | Aug 5, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PFE short interest
Low short interest. 2.4% of PFE shares are sold short: about 1 share in 42. Over the last 12 reports the number of shares short went down 15%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 134.42M PFE shares were sold short, 2.4% of the shares outstanding, down 2.5% from the report before. At the average daily volume of 29.32M shares, buying them all back would take about 4.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 134.42M | 2.36% | -2% | 29.32M | 4.6 |
| Oct 15, 2026 | 137.82M | 2.42% | -8% | 30.83M | 4.5 |
| Sep 30, 2026 | 150.22M | 2.64% | -3% | 34.03M | 4.4 |
| Sep 15, 2026 | 155.20M | 2.72% | +2% | 31.66M | 4.9 |
| Aug 31, 2026 | 151.54M | 2.66% | +2% | 35.02M | 4.3 |
| Aug 14, 2026 | 149.27M | 2.62% | -8% | 42.26M | 3.5 |
| Jul 31, 2026 | 161.48M | 2.83% | -1% | 38.59M | 4.2 |
| Jul 15, 2026 | 163.82M | 2.87% | +0% | 42.81M | 3.8 |
| Jun 30, 2026 | 163.58M | 2.87% | +1% | 60.91M | 2.7 |
| Jun 15, 2026 | 162.08M | 2.84% | -0% | 35.20M | 4.6 |
| May 29, 2026 | 162.66M | 2.85% | +3% | 32.81M | 5.0 |
| May 15, 2026 | 157.46M | 2.76% | +12% | 38.20M | 4.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded PFE
Since Nov 17, 2024, 15 members of Congress reported 11 purchases and 20 sales of PFE. The latest was a sale by Tommy Tuberville on Jun 8, 2026, reported Jul 16, 2026.
Purchases 11Sales 20
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Tommy Tuberville (R-AL) | Sale | $15K–$50K | Joint | Jul 16, 2026 | Report |
| Mar 24, 2026 | Alan Armstrong (R-OK) | Sale | $50K–$100K | Self | Jul 21, 2026 | Report |
| Mar 13, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Apr 7, 2026 | Report |
| Feb 10, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Mar 9, 2026 | Report |
| Dec 31, 2025 | J. French Hill (R-AR) | Sale | $100K–$250K | Self | Jan 23, 2026 | Report |
| Dec 19, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Jan 12, 2026 | Report |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Dec 15, 2025 | Report |
| Aug 5, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Sep 12, 2025 | Report |
| Aug 4, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| Jul 16, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jun 17, 2025 | Julia Letlow (R-LA) | Purchase | $1K–$15K | Self | Jan 13, 2026 | Report |
| Jun 3, 2025 | Josh Gottheimer (D-NJ) | Sale | $1K–$15K | Joint | Jul 16, 2025 | Report |
| Jun 3, 2025 | Ron Wyden (D-OR) | Sale | $1K–$15K | Spouse | Jul 2, 2025 | Report |
| May 30, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Jun 6, 2025 | Report |
| May 15, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $15K–$50K | Self | May 31, 2025 | Report |
| Apr 29, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | May 6, 2025 | Report |
| Apr 21, 2025 | Bruce Westerman (R-AR) | Sale | $1K–$15K | Self | May 12, 2025 | Report |
| Apr 11, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | May 8, 2025 | Report |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $15K–$50K | Self | Apr 28, 2025 | Report |
| Mar 31, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Sale | $15K–$50K | Self | Apr 7, 2025 | Report |
| Mar 10, 2025 | Carol D. Miller (R-WV) | Sale | $15K–$50K | Spouse | Aug 13, 2026 | Report |
| Mar 10, 2025 | Carol D. Miller (R-WV) | Sale | $1K–$15K | Self | Apr 11, 2025 | Report |
| Mar 3, 2025 | Bruce Westerman (R-AR) | Purchase | $1K–$15K | Self | Apr 16, 2025 | Report |
| Feb 26, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Mar 6, 2025 | Report |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $15K–$50K | Self | Mar 27, 2025 | Report |
| Feb 24, 2025 | Jefferson Shreve (R-IN) | Purchase | $15K–$50K | Self | Mar 9, 2025 | Report |
| Feb 13, 2025 | John Boozman (R-AR) | Sale | $1K–$15K | Joint | Mar 6, 2025 | Report |
| Feb 12, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | Mar 12, 2025 | Report |
| Jan 24, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Feb 11, 2025 | Report |
| Jan 15, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Feb 12, 2025 | Report |
| Nov 26, 2024 | Michael A. Rulli (R-OH) | Sale | $1K–$15K | Self | Aug 7, 2026 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Pfizer company events
Pfizer filed 10 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 3, 2026.
- Nov 3, 2026LeadershipPfizer Inc. announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026. Filing
- Nov 3, 2026ResultsReleased financial results. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jun 18, 2026AnnouncementShared information with investors. Filing
- Jun 18, 2026LeadershipDeparture of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Apr 27, 2026VoteReported shareholder vote results. Filing
- Feb 3, 2026ResultsReleased financial results. Filing
- Dec 16, 2025AnnouncementShared information with investors. Filing
- Nov 21, 2025AnnouncementPfizer Inc. completed a public offering of $500 million of Floating Rate Notes due 2027, $1 billion of 3.875% Notes due 2027, $1 billion of 4.200% Notes due 2030, $1.25 billion of 4.500% Notes due 2032, $1.25 billion of 4.875% Notes due 2035, $500 million of 5.600% Notes due 2055 and $500 million… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
How Pfizer makes money
United States brought in 59% of Pfizer's revenue ($37.1B of $62.6B) in 2025. International Developed Markets was next, at 26%.
By region, 2025
From Pfizer's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 26, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money
Pfizer financials
Famous investors that hold PFE
10 of the 50 well-known investors we track reported holding PFE in their latest 13F filing. The largest position is Ken Fisher's, worth $3.2B.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Fisher · Fisher Asset Management | Q3 2026 | 112.12M | $3.2B | 0.9% | +3% |
| Richard Pzena · Pzena Investment Management | Q3 2026 | 6.05M | $173M | 0.5% | +2% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 4.74M | $135M | 0.1% | -23% |
| Jeremy Grantham · GMO | Q3 2026 | 2.26M | $64.6M | 0.1% | +4% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 1.99M | $56.7M | 0.1% | New |
| Israel Englander · Millennium Management | Q3 2026 | 1.74M | $49.6M | 0.0% | +213% |
| Prem Watsa · Fairfax Financial Holdings | Q3 2026 | 1.42M | $40.4M | 1.5% | +36% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 598,828 | $17.1M | 0.1% | -14% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 477,929 | $13.6M | 0.1% | +165% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 96,528 | $2.8M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Pfizer Inc (PFE) stock
Who owns the most PFE stock?
The largest reported owner of Pfizer Inc (PFE) is BlackRock, Inc., with 9.3% of the company. In total, 2,814 funds and institutions reported holding PFE at the end of Q2 2026, together about 71% of the shares. See the largest owners.
Are PFE insiders buying or selling?
In the last 12 months, PFE insiders reported 3 open-market purchases worth $3M and 2 sales worth $135K. The latest trade was on Aug 12, 2026. See every trade.
What is the short interest in PFE?
As of Oct 30, 2026, 134.42M PFE shares were sold short, 2.4% of the shares outstanding, down 2.5% from the report before. At the average daily volume of 29.32M shares, buying them all back would take about 4.6 trading days (days to cover). See the history.
Have members of Congress traded PFE?
Yes. 15 members of Congress reported 11 purchases and 20 sales of PFE since Nov 17, 2024. The latest was reported on Aug 13, 2026. See the trades.
How does Pfizer make money?
United States brought in 59% of Pfizer's revenue ($37.1B of $62.6B) in 2025. International Developed Markets was next, at 26%. See the full split.
Which famous investors hold PFE?
10 of the 50 well-known investors we track reported PFE in their latest 13F filing, including Ken Fisher, Richard Pzena, Ken Griffin. The largest position is worth $3.2B. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.